The impaired skin barrier in AD is characterized by reduced very‐long‐chain epidermal lipids, defective tight junctions, differentiation in protein deficiency (including from filaggrin loss‐of‐function mutations), enhanced protease activity and increased skin‐surface pH. This evidence concerns the gene FLG and Alzheimer disease.